Qinprezo vosaroxin: Pilot trial started

Sunesis said investigators began an open-label, U.S. pilot trial to evaluate IV vosaroxin on days 1 and 4 with once-daily cytarabine in 5-day cycles for up to 4 cycles comprising 2 induction and 2 con...